Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunotherapy in Combination With PARP Inhibition in Advanced Cervical Cancer Patients Functionally Competent or Deficient for the Fanconi Anemia Repair Pathway

NCT04483544 is registered in ClinicalTrials.gov with Baptist Health South Florida as lead sponsor.

NCT NCT04483544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04483544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunotherapy in Combination With PARP Inhibition in Advanced Cervical Cancer Patients Functionally Competent or Deficient for the Fanconi Anemia Repair Pathway
Lead sponsor
Baptist Health South Florida
Phase
Phase 2
Overall status
Terminated
Start date
December 3, 2020
Completion date
December 12, 2024
Enrollment
8 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, cervical carcinoma